These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15660442)

  • 1. Structural accelerated failure time models for survival analysis in studies with time-varying treatments.
    Hernán MA; Cole SR; Margolick J; Cohen M; Robins JM
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):477-91. PubMed ID: 15660442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.
    Cole SR; Hernán MA; Robins JM; Anastos K; Chmiel J; Detels R; Ervin C; Feldman J; Greenblatt R; Kingsley L; Lai S; Young M; Cohen M; Muñoz A
    Am J Epidemiol; 2003 Oct; 158(7):687-94. PubMed ID: 14507605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.
    Hernán MA; Brumback B; Robins JM
    Epidemiology; 2000 Sep; 11(5):561-70. PubMed ID: 10955409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.
    Hernán MA; Brumback BA; Robins JM
    Stat Med; 2002 Jun; 21(12):1689-709. PubMed ID: 12111906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Marginal structural models application to estimate the effects of antiretroviral therapy in 5 cohorts of HIV seroconverters].
    Pérez-Hoyos S; Ferreros I; Hernán MA;
    Gac Sanit; 2007; 21(1):76-83. PubMed ID: 17306191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count.
    Cole SR; Hernán MA; Margolick JB; Cohen MH; Robins JM
    Am J Epidemiol; 2005 Sep; 162(5):471-8. PubMed ID: 16076835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating causal treatment effects from longitudinal HIV natural history studies using marginal structural models.
    Ko H; Hogan JW; Mayer KH
    Biometrics; 2003 Mar; 59(1):152-62. PubMed ID: 12762452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy.
    Barrón Y; Cole SR; Greenblatt RM; Cohen MH; Anastos K; DeHovitz JA; Delapenha R; Gange SJ
    AIDS; 2004 Jul; 18(11):1579-84. PubMed ID: 15238776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented and doubly robust G-estimation of causal effects under a Structural nested failure time model.
    Mertens K; Vansteelandt S
    Biometrics; 2018 Jun; 74(2):472-480. PubMed ID: 28742252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death.
    Cole SR; Jacobson LP; Tien PC; Kingsley L; Chmiel JS; Anastos K
    Am J Epidemiol; 2010 Jan; 171(1):113-22. PubMed ID: 19934191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus.
    López-Gatell H; Cole SR; Hessol NA; French AL; Greenblatt RM; Landesman S; Preston-Martin S; Anastos K
    Am J Epidemiol; 2007 May; 165(10):1134-42. PubMed ID: 17339383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the effects of time-varying treatments: incidence of fractures among postmenopausal Japanese women.
    Tanaka S; Matsuyama Y; Shiraki M; Ohashi Y
    Epidemiology; 2007 Sep; 18(5):529-36. PubMed ID: 17700241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.
    Hogg RS; Bangsberg DR; Lima VD; Alexander C; Bonner S; Yip B; Wood E; Dong WW; Montaner JS; Harrigan PR
    PLoS Med; 2006 Sep; 3(9):e356. PubMed ID: 16984218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model.
    Cole SR; Hernán MA; Anastos K; Jamieson BD; Robins JM
    Am J Epidemiol; 2007 Jul; 166(2):219-27. PubMed ID: 17478436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death.
    Cole SR; Hudgens MG; Tien PC; Anastos K; Kingsley L; Chmiel JS; Jacobson LP
    Am J Epidemiol; 2012 Mar; 175(5):381-90. PubMed ID: 22302074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death.
    Cain LE; Cole SR
    Stat Med; 2009 May; 28(12):1725-38. PubMed ID: 19347843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simulation study of finite-sample properties of marginal structural Cox proportional hazards models.
    Westreich D; Cole SR; Schisterman EF; Platt RW
    Stat Med; 2012 Aug; 31(19):2098-109. PubMed ID: 22492660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era.
    King JT; Justice AC; Roberts MS; Chang CC; Fusco JS;
    Med Decis Making; 2003; 23(1):9-20. PubMed ID: 12583451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.
    Brumback BA; Hernán MA; Haneuse SJ; Robins JM
    Stat Med; 2004 Mar; 23(5):749-67. PubMed ID: 14981673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.